Literature DB >> 8914954

Urinary excretion of 5-L-oxoproline (pyroglutamic acid) is increased during recovery from severe childhood malnutrition and responds to supplemental glycine.

C Persaud1, T Forrester, A A Jackson.   

Abstract

We hypothesized that a limitation in the endogenous formation of glycine might constrain catch-up growth during recovery from severe childhood malnutrition. The urinary excretion of 5-L-oxoproline is increased when the glycine available for glutathione synthesis is limited. Urinary excretion of 5-L-oxoproline was measured throughout recovery in 12 children (aged 16 +/- 6 mo) with severe malnutrition. Urinary 5-L-oxoproline was similar at admission and after recovery, but was increased significantly during rapid catch-up growth. There was a significant relationship between the rate of weight gain and 5-L-oxoproline excretion in urine. In nine children (aged 15 +/- 5 mo), the effect of oral supplementation with glycine, [1.7 mmol/(kg x d) for 48 h] during rapid catch-up growth on 5-L-oxoprolinuria and blood glutathione concentration was determined. In seven of the nine children weight gain was less than 17 g/(kg x d) and following oral glycine supplements 5-L-oxoproline excretion was reduced up to 64% and blood glutathione concentration increased up to 100%. In the two children who were gaining weight at a rate > 17 g/(kg x d), glycine supplementation was associated with a further increase in 5-L-oxoproline excretion and a decrease in blood glutathione. If 5-L-oxoproline is an index of the relative availability of glycine, then the data indicate that glycine may be limiting during rapid catch-up growth. This would have important implications for repletion of muscle and gain in height.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914954     DOI: 10.1093/jn/126.11.2823

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  12 in total

1.  Branch-point stoichiometry can generate weak links in metabolism: the case of glycine biosynthesis.

Authors:  Enrique Melendez-Hevia; Patricia De Paz-Lugo
Journal:  J Biosci       Date:  2008-12       Impact factor: 1.826

2.  A weak link in metabolism: the metabolic capacity for glycine biosynthesis does not satisfy the need for collagen synthesis.

Authors:  Enrique Meléndez-Hevia; Patricia De Paz-Lugo; Athel Cornish-Bowden; María Luz Cárdenas
Journal:  J Biosci       Date:  2009-12       Impact factor: 1.826

3.  Urinary excretion of 5-L-oxoproline (pyroglutamic acid) during early life in term and preterm infants.

Authors:  A A Jackson; C Persaud; M Hall; S Smith; N Evans; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

4.  Profound metabolic acidosis and oxoprolinuria in an adult.

Authors:  Michael J Hodgman; James F Horn; Christine M Stork; Jeanna M Marraffa; Michael G Holland; Richard Cantor; Patti M Carmel
Journal:  J Med Toxicol       Date:  2007-09

Review 5.  Emerging regulatory paradigms in glutathione metabolism.

Authors:  Yilin Liu; Annastasia S Hyde; Melanie A Simpson; Joseph J Barycki
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

6.  A not so simple analgesic.

Authors:  Sarah Howie; Anne Tarn; Charles Soper
Journal:  NDT Plus       Date:  2010-09-08

7.  Long-term patterns of urinary pyroglutamic acid in healthy humans.

Authors:  Richard S Lord
Journal:  Physiol Rep       Date:  2016-02

8.  Exploring the Role of Different Neonatal Nutrition Regimens during the First Week of Life by Urinary GC-MS Metabolomics.

Authors:  Angelica Dessì; Antonio Murgia; Rocco Agostino; Maria Grazia Pattumelli; Andrea Schirru; Paola Scano; Vassilios Fanos; Pierluigi Caboni
Journal:  Int J Mol Sci       Date:  2016-02-22       Impact factor: 5.923

9.  Glycine Increases Insulin Sensitivity and Glutathione Biosynthesis and Protects against Oxidative Stress in a Model of Sucrose-Induced Insulin Resistance.

Authors:  Mohammed El-Hafidi; Martha Franco; Angélica Ruiz Ramírez; José Santamaria Sosa; José Antonio Pineda Flores; Ocarol López Acosta; Monserrath Chávez Salgado; Guillermo Cardoso-Saldaña
Journal:  Oxid Med Cell Longev       Date:  2018-02-21       Impact factor: 6.543

10.  Pyroglutamic Acidemia: An Underrecognized and Underdiagnosed Cause of High Anion Gap Metabolic Acidosis - A Case Report and Review of Literature.

Authors:  Sidish S Venkataraman; Rachel Regone; Hussam M Ammar; Rukma R Govindu
Journal:  Cureus       Date:  2019-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.